Lactobacillus and Bifidobacterium have been well studied as probiotics for IBD intervention due to their well-characterized immunomodulatory effect, such as NF-κB pathway inhibition and IL-10 induction (Wong et al., 2022; Wang et al., 2023; Haque et al., 2024). The gene discussed is IL10; the disease is inflammatory bowel disease.